World Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, Auto-Immune and Others) Market Report 2021 – ResearchAndMarkets.com

World Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, Auto-Immune and Others) Market Report 2021 – ResearchAndMarkets.com




World Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, Auto-Immune and Others) Market Report 2021 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, Auto-Immune and Others)” report has been added to ResearchAndMarkets.com’s offering.

This report focuses on diagnostics. The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2015 to 2024, with 2020 as the base year, providing global biomarker market forecasts for the total biomarker market.

Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications.

Clinical Diagnostic Biomarker Market by Disease

In 2020, growth in the total global market for clinical diagnostic markers has been strong, with strong expansion expected to continue. The report discusses how this growth will be fueled by an aging population that is more susceptible to disease, the increasing number of targeted therapies being developed and introduced, and the large and growing clinical diagnostic test market. Further, analysis in the report of key segments, such as the infectious disease and cancer segments, shows that growth will occur at different rates.

The report provides the following data on segments of the clinical diagnostic biomarker market by disease:

  • Total Global Clinical Diagnostic Biomarker Market, 2015-2025, in $Millions (Cancer, Cardiovascular Disease, Immunological Disease, Infectious Disease, Neurological Disease, Other, Total)
  • Clinical Diagnostic Biomarker Market Segments, 2015, 2020, 2025, by Share (Cancer, Cardiovascular Disease, Immunological Disease, Infectious Disease, Neurological Disease, Other)

Competition in the Market

The World Market for Biomarkers includes profiles of companies active in the discovery and/or commercialization of biomarkers. This includes companies commercializing in vitro diagnostic tests for detection and analysis of biomarkers, selected diagnostic companies commercializing diagnostic tests in their own CLIA certified laboratories for detection and analysis of biomarkers, and selected other players.

The report’s focus is on companies with commercialized products and/or very advanced development programs. The diagnostics market is a highly competitive market, and there are many additional diagnostic companies that offer tests based on biomarkers discussed in this report. Companies profiled in the report range from large, multinational companies to smaller companies in or entering this market,

Key Topics Covered:

Chapter 1: Introduction

  • Report Coverage
  • Methodology
  • Sources of Information

Chapter 2: Executive Summary

Chapter 3: Market Environment & Analysis

  • Overview
  • Demographic Patterns
  • Biomarker Technologies
  • Biomarker Market Analysis
  • Biomarker Products
  • Geographical Markets

Chapter 4: Infectious Disease Biomarkers

  • Overview
  • COVID-19 Biomarkers
  • Respiratory Diseases
  • Pneumonia
  • Influenza
  • Group A Streptococcus Infections
  • Tuberculosis
  • Other Respiratory Infections
  • Healthcare-Associated Infections (HAIs)
  • Clostridioides difficile (c. diff)
  • Sepsis
  • Staphylococcus aureus
  • Enterococcus
  • Other Healthcare-Associated Infections
  • Hepatitis
  • Types of Hepatitis
  • Hepatitis Biomarkers
  • Commercial Hepatitis Tests
  • HIV
  • Overview
  • Statistical Trends
  • Biomarker-Based HIV Tests
  • Commercial HIV Tests
  • Sexually Transmitted Diseases (STDs)
  • Human Papillomavirus (HPV)
  • Chlamydia/Gonorrhea (CT/NG)
  • Trichomoniasis
  • Herpes Simplex Virus (HSV-1 & HSV-2)
  • Other Sexually Transmitted Diseases
  • TORCH
  • Other Infectious Diseases
  • Malaria
  • Lyme Disease
  • coli
  • pylori
  • Dengue
  • All Other Disease

Chapter 5: Cancer Biomarkers

  • Overview
  • Types of Cancer Biomarkers
  • Market Analysis
  • Biomarker Product Suppliers

Chapter 6: Cardiovascular Biomarkers

  • Overview
  • Key Biomarkers
  • Biomarker Product Suppliers

Chapter 7: Clinical Chemistry Biomarkers

  • Overview
  • Blood Gases & Electrolytes
  • Urinanalysis
  • Workstation Immunoassay Tests
  • Market Analysis
  • Biomarker Product Suppliers

Chapter 8: Neurological Biomarkers

  • Overview
  • Key Biomarkers
  • Market Analysis
  • Biomarker Product Suppliers

Chapter 9: Autoimmune Biomarkers

  • Overview
  • Key Biomarkers
  • Market Analysis
  • Biomarker Product Suppliers

Chapter 10: Other Biomarkers

  • Overview
  • Diabetes & Metabolic Biomarkers
  • Fertility & Pregnancy Biomarkers
  • Kidney Disorders
  • Inherited Diseases

    • Cystic Fibrosis
    • Down Syndrome
    • Sickle Cell Disease
    • Gaucher Disease
    • Familial Hypercholesterolemia
    • Muscular Dystrophy
    • Hemophilia
    • Von Willebrand Disease
    • Neurofibromatosis
    • Polycystic Kidney Disease
    • Spinal Muscle Atrophy
    • Klinefelter Syndrome
    • Canavan disease
    • Cerebral Palsy
    • Angelman Syndrome (AS)
    • Other Inherited Diseases
  • Thyroid Conditions
  • All Other Biomarkers

    • Bone Disease Biomarkers
    • Gastrointestinal Biomarkers
    • Respiratory Biomarkers

Chapter 11: Company Profiles

  • Roche Diagnostics (Basel, Switzerland)

    • Molecular Testing
    • Companion Diagnostics
    • Circulating Tumor Cells
  • Abbott Diagnostics (Abbott Park, Illinois)

    • COVID-19
    • Point-of-Care Tests
    • Core Laboratory
    • Molecular Assays
    • Companion Diagnostics
    • Liquid Biopsy
  • Danaher Corporation (Washington, D.C.)

    • Cepheid
    • Radiometer
    • Beckman Coulter
    • Leica Biosystems
  • Thermo Fisher Scientific (Waltham, Massachusetts)
  • Siemens Healthineers (Malvern, Pennsylvania)
  • Becton Dickinson, and Company – BD (Franklin Lakes, New Jersey)
  • bioMerieux (Marcy l’Etoile, France)
  • Illumina (San Diego, California)
  • Ortho Clinical Diagnostics (Raritan, New Jersey)
  • Quidel Corporation (San Diego, California)
  • Exact Sciences (Madison, Wisconsin)
  • Bio-Rad Laboratories (Hercules, California)
  • DiaSorin Group (Saluggia, Italy)
  • Myriad Genetics (Salt Lake City, Utah)
  • Luminex Corporation (Austin, Texas)

For more information about this report visit https://www.researchandmarkets.com/r/o9h5lc

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900